RZLT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RZLT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Rezolute's enterprise value is $247.55 Mil. Rezolute's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil. Therefore, Rezolute's EV-to-Revenue for today is .
The historical rank and industry rank for Rezolute's EV-to-Revenue or its related term are showing as below:
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2025-05-25), Rezolute's stock price is $3.89. Rezolute's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00. Therefore, Rezolute's PS Ratio for today is .
The historical data trend for Rezolute's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rezolute Annual Data | |||||||||||||||||||||
Trend | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | Jun24 | |||||||||||
EV-to-Revenue | Get a 7-Day Free Trial |
![]() |
![]() |
- | - | - | - | - |
Rezolute Quarterly Data | ||||||||||||||||||||
Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | |
EV-to-Revenue | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
For the Biotechnology subindustry, Rezolute's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Rezolute's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Rezolute's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
Rezolute's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 247.553 | / | 0 | |
= |
Rezolute's current Enterprise Value is $247.55 Mil.
Rezolute's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rezolute (NAS:RZLT) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
Rezolute's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 3.89 | / | 0 | |
= |
Rezolute's share price for today is $3.89.
Rezolute's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Rezolute's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Wladimir Hogenhuis | director | 60 LEVERONI COURT, NOVATO CA 94949 |
Nevan C Elam | director, 10 percent owner, officer: Chief Executive Officer | C/O NEKTAR THERAPEUTICS, 150 INDUSTRIAL ROAD, SAN CARLOS CA 94070 |
Young-jin Kim | director | 49, BONGEUNSA-RO 49-GIL, GANGNAM-GU, SEOUL M5 06100 |
Brian Kenneth Roberts | officer: Chief Medical Officer | C/O REZOLUTE, INC., 201 REDWOOD SHORES PARKWAY, SUITE 315, REDWOOD CITY CA 94065 |
Handok, Inc. | 10 percent owner | 132, TEHERAN-RO, GANGNAM GU, SOUL M5 06235 |
Gil M Labrucherie | director | 150 INDUSTRIAL ROAD, SAN CARLOS CA 94070 |
Nerissa Kreher | director | C/O AVROBIO, INC., ONE KENDALL SQ., BLDG. 300, STE. 201, CAMBRIDGE MA 02139 |
Philippe Fauchet | director | C/O REZOLUTE, INC., 201 REDWOOD SHORES PARKWAY, SUITE 315, REDWOOD CITY CA 94065 |
Junghee Lim | director | C/O REZOLUTE, INC., 201 REDWOOD SHORE'S PARKWAY, SUITE 315, REDWOOD CITY CA 94065 |
Genexine Inc. | 10 percent owner | 700 DAEWANGPANGYO-RO, KOREA PARKBLDG. B, BUNDANG-GU, SEONGNAM-SI, GYEONGGI-DO M5 13488 |
Seline E. Miller | officer: VP Finance & CAO | C/O REZOLUTE, INC., 1450 INFINITE DRIVE, LOUISVILLE CO 80027 |
Young Chul Sung | director | 101DONG 404HO, PARKTOWER APT. 69, SEOBINGGO-RO, YONGSAN-GU, SEOUL M5 04385 |
Keith A. Vendola | officer: Chief Financial Officer | 111 LIVORNO WAY, REDWOOD CITY CA 94065 |
Xoma Corp | 10 percent owner | 2200 POWELL STREET, SUITE 310, EMERYVILLE CA 94608 |
David F Welch | director | C/O INFINERA CORPORATION, 140 CASPIAN COURT, SUNNYVALE CA 94089 |
From GuruFocus
By GuruFocus Research • 09-25-2024
By GuruFocus Research • 02-08-2024
By GuruFocus News • 02-22-2025
By GuruFocus News • 03-07-2025
By GuruFocus Research • 02-08-2024
By Marketwired • 06-24-2024
By Marketwired • 03-26-2025
By Marketwired • 12-05-2024
By Marketwired • 06-14-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.